We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Electronic data capture (EDC) for clinical trials has not caught on with the industry as much as had been hoped, admits an executive of a leading EDC vendor.
The FDA has given clearance for a Phase I/II clinical trial of Hollis-Eden’s investigational compound Neumune, which combats healthcare-associated (nosocomial) infections.
Almost 90 percent of patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) were alive five years after they began receiving Gleevec (imatinib), drugmaker Novartis announced at the 2006 annual meeting of the American Society of Clinical Oncology on June 3.
Scios, a division of Johnson & Johnson (J&J), has announced plans to launch a large-scale international study, involving upwards of 7,000 patients, to further assess the benefits and safety profile of its cardiovascular drug Natrecor in people with acutely decompensated heart failure (DHF).
The World Health Organization (WHO) has launched an effort with the lofty goal of registering every clinical trial -- including preliminary studies -- that tests treatments on patients or healthy volunteers globally.
The World Health Organization (WHO) has launched an effort with the lofty goal of registering every clinical trial -- including preliminary studies -- that tests treatments on patients or healthy volunteers globally.
Medidata Solutions, which provides electronic data capture (EDC), management and reporting solutions, announced revenue growth of 152 percent in the first quarter of 2006 compared to the corresponding period of last year.
Senior citizens using Merck’s arthritis medication Vioxx faced the highest risk of heart attack during their first two weeks on the drug, according to a study published in the Canadian Medical Association Journal.
It is not yet clear how much time and money electronic data capture (EDC) will save for clinical trials despite its expectations, a veteran of dozens of trials in the U.S. and Canada said.